Publications by authors named "V Mosseri"

Claim this Profile
A
Atypical Neuroblastoma With Absent Urinary Catecholamine Excretion and ImIBG Avidity Are of Favorable Outcome: A Retrospective French Single-Center Study.
Anna Borovkov, Juliette Assy, Isabelle Aerts, Franck Bourdeaut, Camille Cordero, Véronique Mosseri

Pediatr Blood Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of F-FDG-PET/CT in the initial staging of very high-risk Ewing Sarcoma in a prospective multicentric Phase II Study: Is there still a place for bone marrow sampling?
Nina Jehanno, Nadège Corradini, Nathalie Gaspar, Mehdi Brahmi, Thibaud Valentin, Veronique Mosseri

Br J Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent Olaparib and Radiotherapy in Patients With Triple-Negative Breast Cancer: The Phase 1 Olaparib and Radiation Therapy for Triple-Negative Breast Cancer Trial.
Pierre Loap, Delphine Loirat, Frederique Berger, Manuel Rodrigues, Louis Bazire, Veronique Mosseri

JAMA Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SIOP PNET5 MB Trial: History and Concept of a Molecularly Stratified Clinical Trial of Risk-Adapted Therapies for Standard-Risk Medulloblastoma.
Martin Mynarek, Till Milde, Laetitia Padovani, Geert O Janssens, Robert Kwiecien, Veronique Mosseri

Cancers (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of Olaparib with radiotherapy for triple-negative breast cancers: One-year toxicity report of the RADIOPARP Phase I trial.
Pierre Loap, Delphine Loirat, Frederique Berger, Kim Cao, Francesco Ricci, Veronique Mosseri

Int J Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis